| ADT | Androgen-deprivation therapy |
| AKT | V-akt murine thymoma viral oncogene homolog |
| ALP | Alkaline phosphatase |
| AR | Androgen receptor |
| ARSIs | Androgen receptor signaling inhibitors |
| AR-V7 | AR splice variant 7 |
| BAP | Bone-specific alkaline phosphatase |
| BMM | Bone metabolic markers |
| BSI | Bone scan index |
| cf-DNA | Circulating cell-free DNA |
| CICP | C-terminal of type-1 collagen pro-peptide |
| CPS | Combined Positive Score |
| CSS | Cancer-specific survival |
| CTC | Circulating tumor cells |
| ct-DNA | Circulating tumor DNA |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 |
| CTP | C-telopeptide |
| CYP17A1 | Cytochrome P450 17 alpha-hydroxylase/17,20 lyase |
| DBD | DNA-binding domain |
| DHEA | Dehydroepiandrosterone |
| DHT | Dihydrotestosterone |
| dMMR | Mismatch repair deficiency |
| DNA | Deoxyribonucleic acid |
| dsDNA | Double stranded DNA |
| ESR | Erythrocyte sedimentation rate |
| ERG | E26 transformation-specific (ETS)-related gene |
| FDA | Food and Drug Administration |
| HRR | Homologous recombination repair |
| HSD3B1 | 3-beta-hydroxysteroid dehydrogenase-1 |
| ICI | Immune checkpoint inhibitors |
| LBD | Ligand-binding domain |
| LDH | Lactate dehydrogenase |
| LHRH | Luteinizing hormone-releasing hormone |
| mCRPC | Metastatic castration-resistant prostate cancer |
| mHSPC | Metastatic hormone-naïve/sensitive prostate cancer |
| MMR | Mismatch repair |
| mRNA | Messenger ribonucleic acid |
| MSI | Microsatellite instability |
| NCI | National Cancer Institute |
| NLR | Neutrophil-to-lymphocyte ratio |
| NTD | N-terminal domain |
| NTx | N-telopeptide |
| ORR | Objective response rate |
| OS | Overall survival |
| P1NP | N-terminal propeptide of collagen-1 |
| PARP | Poly (ADP-ribose) polymerase |
| PD-1 | Programmed-death receptor-1 |
| PDL-1 | Programmed-death ligand-1 |
| PET/CT | Positron emission tomography/computed tomography |
| PFS | Progression free survival |
| PI3K | Phosphatidylinositol 3-kinase |
| PSA | Prostate-specific antigen |
| PSADT | PSA doubling time |
| PSMA | Prostate-specific membrane antigen |
| PTEN | Phosphatase and tensin homologue |
| PYD | Pyridinoline |
| rPFS | Radiographic progression free survival |
| RT-PCR | Reverse-transcriptase polymerase chain reaction |
| SLFN11 | Schlafen family member-11 DNA/RNA helicase |
| SOX9 | SRY-related HMG box-9 |
| ssDNA | Single-stranded DNA |
| SUV | Standardized uptake value |
| tALP | Total alkaline phosphatase |
| TMB | Tumor mutational burden |
| 68Ga | Gallium-68 |
| 89Sr | Strontium-89 |
| 153Sm | Samarium-153 |
| 177Lu | Lutetium-177 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.